Gaithersburg, MD-based Emergent BioSolutions (EBS -2.6%) will be featured on a 60 Minutes segment this Sunday, November 15, on Operation Warp Speed. The company is producing COVID-19 vaccines for Johnson & Johnson (JNJ +0.0%) and AstraZeneca (AZN -2.3%). Specifically, it is scaling up both products into bulk drug substance that will be used in the final "fill and finish" manufacturing phase.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.